Renalytix Plc (AIM:RENX)
United Kingdom · Delayed Price · Currency is GBP · Price in GBX 5.35
-0.20 (-3.59%)
Nov 6, 2026, 4:20 PM GMT
Renalytix Balance Sheet
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Equivalents | 1.4 | 3.6 | 4.7 | 24.68 | 41.33 |
Trading Asset Securities | - | 0.1 | 0.7 | - | - |
Cash & Short-Term Investments | 1.4 | 3.7 | 5.4 | 24.68 | 41.33 |
Cash Growth | -62.16% | -31.48% | -78.12% | -40.28% | -36.54% |
Accounts Receivable | 0.7 | 0.6 | 0.7 | 0.78 | 0.9 |
Receivables | 0.7 | 0.6 | 0.7 | 0.78 | 0.98 |
Inventory | 0.5 | 0.2 | 0.3 | - | - |
Prepaid Expenses | 0.6 | 1.2 | 0.4 | 1.42 | 2.45 |
Other Current Assets | 0.1 | 0.1 | - | - | - |
Total Current Assets | 3.3 | 5.8 | 6.8 | 26.88 | 44.75 |
Property, Plant & Equipment | 1.2 | 0.2 | 0.2 | 1.19 | 1.37 |
Long-Term Investments | - | - | - | 1.46 | 2.75 |
Other Long-Term Assets | 0.1 | 0.1 | 0.1 | 1.1 | 1.19 |
Total Assets | 4.6 | 6.1 | 7.1 | 30.63 | 50.07 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Accounts Payable | 5.2 | 4.8 | 7.6 | 2.94 | 2.46 |
Accrued Expenses | - | - | - | 7.93 | 4.39 |
Current Portion of Long-Term Debt | - | - | 4.2 | 4.46 | 4.66 |
Current Portion of Leases | 0.2 | - | - | 0.13 | - |
Current Unearned Revenue | - | - | - | - | 0.05 |
Other Current Liabilities | - | - | - | 0.68 | 0.22 |
Total Current Liabilities | 5.4 | 4.8 | 11.8 | 16.14 | 11.78 |
Long-Term Debt | 4.6 | 8.3 | 4.3 | 7.49 | 7.68 |
Long-Term Leases | 0.9 | - | - | 0.04 | - |
Total Liabilities | 10.9 | 13.1 | 16.1 | 23.66 | 19.46 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Common Stock | 1.4 | 1.1 | 0.5 | 0.29 | 0.23 |
Additional Paid-In Capital | 154.2 | 141.3 | 121.8 | 186.46 | 164.01 |
Retained Earnings | -179.3 | -165.1 | -144.7 | -178.33 | -132.72 |
Comprehensive Income & Other | 17.4 | 15.7 | 13.4 | -1.45 | -0.92 |
Shareholders' Equity | -6.3 | -7 | -9 | 6.97 | 30.61 |
Total Liabilities & Equity | 4.6 | 6.1 | 7.1 | 30.63 | 50.07 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Total Debt | 5.7 | 8.3 | 8.5 | 12.12 | 12.34 |
Net Cash (Debt) | -4.3 | -4.6 | -3.1 | 12.56 | 28.99 |
Net Cash Growth | - | - | - | -56.67% | -55.49% |
Net Cash Per Share | -0.01 | -0.02 | -0.03 | 0.15 | 0.39 |
Filing Date Shares Outstanding | 437.02 | 437.02 | 165.93 | 95.02 | 74.89 |
Total Common Shares Outstanding | 437.02 | 331.21 | 154.37 | 93.78 | 74.76 |
Working Capital | -2.1 | 1 | -5 | 10.75 | 32.98 |
Book Value Per Share | -0.01 | -0.02 | -0.06 | 0.07 | 0.41 |
Tangible Book Value | -6.3 | -7 | -9 | 6.97 | 30.61 |
Tangible Book Value Per Share | -0.01 | -0.02 | -0.06 | 0.07 | 0.41 |
Machinery | - | 0.5 | 0.5 | 1.3 | 1.3 |
Leasehold Improvements | - | - | - | 0.58 | 0.58 |